Citalopram vs Durvalumab

Citalopram vs Durvalumab: Overview

This comparison examines the pharmacological differences between Citalopram and Durvalumab.

Mechanism of Action

Citalopram: Selective serotonin reuptake inhibitor (SSRI); racemic mixture with escitalopram as active S-enantiomer.

Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

Pharmacokinetics

Half-life: Citalopram — 35 hours; Durvalumab — 17 days.

Chemical Properties

Molecular Formula: Citalopram — C20H21FN2O.

Molecular Weight: Citalopram — 324.3920 g/mol.

Type: Citalopram — Small molecule; Durvalumab — Antibody.